SARS-CoV2 spike protein displays biologically significant similarities with paramyxovirus surface proteins; a bioinformatics study
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Recent emergence of SARS-CoV2 and associated COVID-19 pandemic has posed a great challenge for the scientific community. Understanding various aspects of SARS-CoV2 biology, virulence and pathogenesis as well as determinants of immune response have become a global research priority. In this study, we performed bioinformatic analyses on SAR-CoV2 protein sequences, trying to unravel biologically important similarities between this newly emerged virus with other RNA viruses. Comparing the proteome of SARS-CoV2 with major positive and negative strand ssRNA viruses showed significant homologies between SARS-CoV2 spike protein with pathogenic paramyxovirus fusion proteins. This ‘spike-fusion’ homology was not limited to SARS-CoV2 and it existed for some other pathogenic coronaviruses; nonetheless, SARS-CoV2 spike-fusion homology was orders of magnitude stronger than homologies observed for other known coronaviruses. Moreover, this homology did not seem to be a consequence of general ssRNA virus phylogenetic relations. We also explored potential immunological significance of this spike-fusion homology. Spike protein epitope analysis using experimentally verified data deposited in Immune Epitope Database (IEDB) revealed that the majority of spike’s T cell epitopes as well as many B cell and MHC binding epitopes map within the spike-fusion homology region. Overall, our data indicate that there might be a relation between SARS-CoV2 and paramyxoviruses at the level of their surface proteins and this relation could be of crucial immunological importance.
Article activity feed
-
SciScore for 10.1101/2020.07.20.210534: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Extracting SARS-CoV2 and other coronavirus protein sequences: SARS-CoV2 Reference Protein sequences were obtained from NCBI Protein database ( NCBI Proteinsuggested: (NCBI Protein, RRID:SCR_003257)https://www.ncbi.nlm.nih.gov/protein). https://www.ncbi.nlm.nih.gov/proteinsuggested: (Protein Database, RRID:SCR_017486)RefSeq accession numbers and their associated official gene games are shown in Supplemental Table 1. RefSeqsuggested: (RefSeq, RRID:SCR_003496)Pairwise BLASTP search was used to find the distribution of these epitopes on spike protein. BLASTPsuggested: (BLASTP, RRID:SCR_001010)Mult… SciScore for 10.1101/2020.07.20.210534: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Extracting SARS-CoV2 and other coronavirus protein sequences: SARS-CoV2 Reference Protein sequences were obtained from NCBI Protein database ( NCBI Proteinsuggested: (NCBI Protein, RRID:SCR_003257)https://www.ncbi.nlm.nih.gov/protein). https://www.ncbi.nlm.nih.gov/proteinsuggested: (Protein Database, RRID:SCR_017486)RefSeq accession numbers and their associated official gene games are shown in Supplemental Table 1. RefSeqsuggested: (RefSeq, RRID:SCR_003496)Pairwise BLASTP search was used to find the distribution of these epitopes on spike protein. BLASTPsuggested: (BLASTP, RRID:SCR_001010)Multiple sequence alignment (MSA) and phylogenetic analysis were performed using MEGA X and PhyML(10). MEGAsuggested: (Mega BLAST, RRID:SCR_011920)MUSCLE algorithm was used to perform MSA between sequences. MUSCLEsuggested: (MUSCLE, RRID:SCR_011812)Phylogenetic tree construction was performed in PhyML and MEGAX. PhyMLsuggested: (PhyML, RRID:SCR_014629)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-